Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

NCT04671017 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Virus Infection

Interventions

BIOLOGICAL: VLA2001

Sponsor

Valneva Austria GmbH

Collaborators

[object Object]